S Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
SentinelOne is not a good buy right now for a beginner long-term investor with impatience and $50,000-$100,000 to deploy. The stock is under heavy pre-market pressure after weak guidance and layoffs, while the technical setup is mixed and the recent trend expectations are still negative over the next week and month. Despite some bullish analyst upgrades and improving product mix, I would not buy it immediately today.
The short-term trend is weak in pre-market, with the stock down 15.95% to 15.145. Technically, the structure is mixed: MACD histogram is positive but contracting, RSI_6 at 61.762 is neutral-to-mildly bullish, and moving averages are constructive with SMA_5 > SMA_20 > SMA_200. However, the current price is below the pivot (17.453) and near S2 support (15.568), showing clear post-earnings damage. The provided pattern-based outlook is also soft, with expected downside of -1.49% next week and -1.33% next month.
Several analysts pointed to improved execution in AI security, data, and cloud, plus a stronger non-endpoint mix. The company also has a path to margin expansion, and some analysts view the post-drop valuation as attractive.
SentinelOne’s Q1 revenue missed expectations and Q2 guidance came in below consensus, triggering a sharp pre-market selloff. The company announced an 8% workforce reduction, which markets interpreted as a sign of growth concerns. News sentiment is clearly negative after the earnings miss and guidance cut. Raymond James downgraded the stock sharply, and multiple firms lowered price targets. Insider selling has increased 847.69% over the last month, and hedge funds are neutral with no significant buying trend. There is no congress trading support and no political/influential buying signal.
Latest quarter: Q1 FY2027. Revenue increased 21% year over year to $277 million, but it missed analyst expectations. Annual recurring revenue growth accelerated, and non-endpoint solutions reached roughly half of total ARR for the first time, which is a positive structural trend. However, the company guided Q2 revenue below expectations, which overshadowed the solid growth and indicates a softer near-term outlook.
Analyst sentiment is mixed but leaning cautious. Positive moves include BofA upgrading to Buy with a $20 target, Canaccord keeping Buy with an $18 target, and Jefferies raising to $24 with a Buy rating. Negative moves include JPMorgan lowering its target and keeping Neutral, UBS lowering its target and keeping Neutral, Barclays lowering its target, and Raymond James downgrading to Market Perform from Strong Buy. Overall, Wall Street sees long-term product momentum and valuation upside, but near-term execution and guidance concerns are dominating the view.
